ROIV position history
The shares of Roivant Sciences (ROIV) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q4: 176,477,400 shares, $1.8B, 5.1% of portfolio, New
- 2022 Q1: 88,238,700 shares, $436M, 1.8% of portfolio, Reduce −50.0%
- 2022 Q2: 88,238,700 shares, $359M, 1.6% of portfolio
- 2022 Q3: 88,238,700 shares, $284M, 1.3% of portfolio
- 2022 Q4: 88,238,700 shares, $705M, 3.5% of portfolio
- 2023 Q1: 88,238,700 shares, $651M, 3.1% of portfolio
- 2023 Q2: 75,238,700 shares, $758M, 3.1% of portfolio, Reduce −14.7%
- 2023 Q3: 73,434,301 shares, $858M, 3.5% of portfolio, Reduce −2.4%
- 2023 Q4: 69,368,961 shares, $779M, 2.9% of portfolio, Reduce −5.5%
- 2024 Q1: 69,368,961 shares, $731M, 2.7% of portfolio
- 2024 Q2: 69,155,846 shares, $731M, 2.8% of portfolio, Reduce −0.3%
- 2024 Q3: 54,099,066 shares, $624M, 2.3% of portfolio, Reduce −21.8%
- 2024 Q4: 47,809,960 shares, $566M, 1.8% of portfolio, Reduce −11.6%
- 2025 Q1: 46,013,752 shares, $464M, 1.5% of portfolio, Reduce −3.8%
- 2025 Q2: 34,237,779 shares, $386M, 1.1% of portfolio, Reduce −25.6%
- 2025 Q3: 23,594,831 shares, $357M, 0.93% of portfolio, Reduce −31.1%
- 2025 Q4: 6,443,191 shares, $140M, 0.37% of portfolio, Reduce −72.7%
- 2026 Q1: 6,652,448 shares, $184M, 0.52% of portfolio, Add +3.2%
- 2026 Q2: 6,271,467 shares, $222M, 0.63% of portfolio, Reduce −5.7%
- 2026 Q3: 6,757,326 shares, $247M, 0.76% of portfolio, Add +7.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|